Transglutaminase 3 reduces the severity of psoriasis in imiquimod‐treated mouse skin

13Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Four transglutaminase (TG) isoforms have been detected in epidermal keratinocytes: TG1, TG2, TG3, and TG5. Except for TG1 and TG3, their contribution to keratinocyte development and structure remains undefined. In this paper, we focused on the roles of TG2 and TG3 in imiquimod-induced psoriasis in mouse skin. We evaluated the severity of psoriasis markers in the skin of imiquimod‐treated TG3 null and TG2 null mice. Our results showed that compromised TG3KO mouse skin was more responsive than WT or TG2KO mouse skin to the action of the proinflammatory drug imiquimod.

Cite

CITATION STYLE

APA

Piro, M. C., Ventura, A., Smirnov, A., Saggini, A., Lena, A. M., Mauriello, A., … Candi, E. (2020). Transglutaminase 3 reduces the severity of psoriasis in imiquimod‐treated mouse skin. International Journal of Molecular Sciences, 21(5). https://doi.org/10.3390/ijms21051566

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free